Editorials | Regulatory Rapporteur

Regulatory Rapporteur Editorials

Patient evidence and engagement
2023-01-04T11:14:00+00:00By Kasia Nowok, Richard Huckle
Adapting, transforming and innovating
2022-10-31T14:40:00+00:00By Leah Kleylein, Nancy Pire-Smerkanich
Waltzing into change in Vienna:
The regulatory future comes into focus
2022-12-05T01:00:00+00:00By Julie Warner, Pascale Canning
October 2022 Editorial: Great expectations for medical technologies
2022-09-16T09:26:00+01:00By Stephen Dew, Jillian Stewart
September 2022 Editorial: Regulatory operations: Evolution and revolution
2022-08-22T00:01:00+01:00By Julie Warner, Victoria Goff
July/August 2022 Editorial - A new era of digital and data-driven innovations
2022-06-16T10:06:00+01:00By Kasia Nowok, Patricia Hurley
June 2022 Editorial: How regulators are navigating the evolving pharmacovigilance landscape
2022-05-20T15:51:00+01:00By Birgit Roser, Julie Warner
May 2022 Editorial: CMC acceleration is driven by a scientific revolution
2022-05-13T14:51:00+01:00By Victoria Goff, Satish Muchakayala
April 2022 Editorial: The future of pharmaceuticals is green
2022-03-24T13:14:00+00:00By Birgit Roser, Stephen Dew
March 2022 Editorial: The UK and Brexit – innovation and optimism in uncertain times
2022-02-23T14:10:00+00:00By Sobhey Nassar, Jillian Stewart
February 2022 Editorial: Regulatory support for drug development – maximising options for timely patient access
2022-01-26T10:48:00+00:00By Joan Boren, Marie Deneux
January 2022 Editorial: What does 2022 have in store for clinical trials?
2021-12-23T13:39:00+00:00By Nancy Pire-Smerkanich, Ilse-Maria Nolan
December 2021 Editorial: A regulatory revolution – driven by data
2021-11-23T09:57:00+00:00By Pascale Canning, Theresa Jeary